PCV19 THE COST-EFFECTIVENESS ANALYSIS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60933-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)60933-3/fulltext
Section Title :
Section Order :
121
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60933-3&doi=10.1016/S1098-3015(10)60933-3